Holly Hill
8PUBLICATIONS
64CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 02, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.Clinton Yam, Miral Patel, Holly A Hill
|Aug 04, 2023
Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma.Holly A Hill, Preetesh Jain, Chi Young Ok
|Feb 16, 2023
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations.Yuxuan Che, Yang Liu, Yixin Yao
|Nov 19, 2021
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.Preetesh Jain, Shuangtao Zhao, Hun Ju Lee
|May 18, 2021
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.Shaojun Zhang, Vivian Changying Jiang, Guangchun Han
|Apr 03, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria
Pageof 2
Frequent Collaborators
7 joint publications
Michael Wang
5 joint publications
Chi Young Ok
5 joint publications
Preetesh Jain
3 joint publications
Shaojun Zhang
3 joint publications
Linghua Wang
3 joint publications
Yang Liu
3 joint publications
Yixin Yao
2 joint publications
Guilin Tang
2 joint publications
Vivian Changying Jiang
2 joint publications
Ken Chen
